Literature DB >> 24905374

Emerging drugs of abuse: clinical and legal considerations.

Elie G Aoun1, Paul P Christopher2, James W Ingraham3.   

Abstract

Over the past several decades, nontraditional drugs of abuse, including bath salts, synthetic cannabinoids, and salvia, have increased in popularity and use. Despite this fact, they remain unfamiliar to many healthcare providers. Commonly marketed as "legal highs," these substances are being used for their desired neuropsychiatric effects, taking advantage of their accessibility, low cost, variable legality, and limited detection on traditional urine drug screens. Similar to traditional drugs of abuse, these substances have varying degrees of toxicity and may lead to potentially adverse effects, ranging from benign to life threatening. This paper offers a review of three of the more widely-used emerging drugs (or classes of drugs): bath salts, synthetic cannabinoids, and salvia. For each we review its history and development, the neurochemical basis for its clinical effects, the nature and route of ingestion, the range of desired effects, potential toxicities, diagnostic and therapeutic approaches, as well as social and legal considerations. [Full text available at http://rimed.org/rimedicaljournal-2014-06.asp, free with no login].

Entities:  

Keywords:  Emerging drugs; bath salts; drug abuse; salvia; synthetic cannabinoids

Mesh:

Substances:

Year:  2014        PMID: 24905374

Source DB:  PubMed          Journal:  R I Med J (2013)        ISSN: 0363-7913


  7 in total

1.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

2.  Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies.

Authors:  Adebisi I Obafemi; Kurt Kleinschmidt; Collin Goto; Drew Fout
Journal:  J Med Toxicol       Date:  2015-12

3.  Intravenous Lipid Emulsion Therapy for Acute Synthetic Cannabinoid Intoxication: Clinical Experience in Four Cases.

Authors:  Gökhan Aksel; Özlem Güneysel; Tanju Taşyürek; Ergül Kozan; Şebnem Eren Çevik
Journal:  Case Rep Emerg Med       Date:  2015-05-11

4.  Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine.

Authors:  Israr A Sheikh; Miha Lukšič; Richard Ferstenberg; Joan A Culpepper-Morgan
Journal:  Am J Case Rep       Date:  2014-12-30

Review 5.  Cannabis, cannabinoids, and health.

Authors:  Genevieve Lafaye; Laurent Karila; Lisa Blecha; Amine Benyamina
Journal:  Dialogues Clin Neurosci       Date:  2017-09       Impact factor: 5.986

6.  Concomitant Substance Use Increases the Toxic Effect of synthetic cannabinoid (Bonsai): A Prospective Study.

Authors:  İnan Beydilli; Murat Duyan; Fevzi Yılmaz; Engin Deniz Arslan; İlhan Korkmaz; Mehmet Akçimen; Mustafa Keşaplı; Arefe İmak; Umut Cengiz Çakır; Cemil Kavalcı; Ertan Ararat; Hamit Ellidağ
Journal:  Acta Biomed       Date:  2020-08-25

7.  Designer Drugs: A Synthetic Catastrophe.

Authors:  James Fratantonio; Lawrence Andrade; Marcelo Febo
Journal:  J Reward Defic Syndr       Date:  2015-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.